ELCAPSUR

Class [005]
Pharmaceutical preparations for the prevention and treatment of auto immune disorders, disorders of the central nervous system, namely ischemic stroke, cerebral infarction, transient ischemic attack, hemorrhagic stroke, traumatic brain injury, malignant hypertension, HIV-associated stroke, cerebral malaria and TTP (Thrombotic Thrombocytopenic Purpura) related neurological symptoms, the cardio-vascular system, the respiratory system, the genitourinary system, namely, renal injury, renal failure and malignant hypertension, for the treatment of inflammatory disorders, namely reperfusion injury, sepsis and SIRS (Systemic Inflammatory Response Syndrome), skin disorders, namely cutaneous inflammation, ANCA (Anti-Neutrophil Cytoplasmic Antibody) associated vasculitis and (systemic) scleroderma, and for use in hematology, namely, congenital and acquired thrombotic thrombocytopenic purpura, sickle cell disease, arterial thrombosis, (transplant-associated) thrombotic microangiopathy, thrombo-prophylaxis, von Willebrand disease type 2B, disseminated intravascular coagulation, cushing's syndrome, idiopathic non-cirrhotic intrahepatic portal hypertension, HELLP (Hemolysis (H), Elevated Liver enzymes (EL) and Low Platelet count (LP)), preeclampsia, liver cirrhosis, primary aldosteronism, osteonecrosis of the femoral head, (tumor) angiogenesis, acute myelogenous leukemia, arthroplasty-associated thrombosis, deep vein thrombosis, pulmonary embolism, mesenteric ischemia, (catastrophic) anti-phospholipid syndrome, hemolytic uremic syndrome, and other diseases where intravascular coagulation needs to be restored, and in tissue and organ transplantation; pharmaceutical drugs, namely prescription medicines, for administration by injection or infusion, for the prevention and treatment of auto immune disorders, disorders of the nervous system, namely ischemic stroke, cerebral infarction, transient ischemic attack, hemorrhagic stroke, traumatic brain injury, malignant hypertension, HIV-associated stroke, cerebral malaria and TTP (Thrombotic Thrombocytopenic Purpura) related neurological symptoms, the cardio-vascular system, the respiratory system, the genitourinary system, namely, renal injury, renal failure and malignant hypertension, for the treatment of inflammatory disorders, namely reperfusion injury, sepsis and SIRS (Systemic Inflammatory Response Syndrome), skin disorders, namely cutaneous inflammation, ANCA (Anti-Neutrophil Cytoplasmic Antibody) associated vasculitis and (systemic) scleroderma and for use in hematology, namely congenital and acquired thrombotic thrombocytopenic purpura, sickle cell disease, arterial thrombosis, (transplant-associated) thrombotic microangiopathy, thrombo-prophylaxis, von Willebrand disease type 2B, disseminated intravascular coagulation, cushing's syndrome, idiopathic non-cirrhotic intrahepatic portal hypertension, HELLP (Hemolysis (H), Elevated Liver enzymes (EL) and Low Platelet count (LP)), preeclampsia, liver cirrhosis, primary aldosteronism, osteonecrosis of the femoral head, (tumor) angiogenesis, acute myelogenous leukemia, arthroplasty-associated thrombosis, deep vein thrombosis, pulmonary embolism, mesenteric ischemia, (catastrophic) anti-phospholipid syndrome, hemolytic uremic syndrome.